Your browser doesn't support javascript.
loading
Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial.
Leiter, L A; Teoh, H; Mosenzon, O; Cahn, A; Hirshberg, B; Stahre, C A M; Hoekstra, J B L; Alvarsson, M; Im, K; Scirica, B M; Bhatt, D L; Raz, I.
Affiliation
  • Leiter LA; Division of Endocrinology & Metabolism, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Teoh H; Division of Endocrinology & Metabolism, Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Mosenzon O; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, Toronto, ON, Canada.
  • Cahn A; Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University-Medical Center, Jerusalem, Israel.
  • Hirshberg B; Diabetes Unit, Division of Internal Medicine, Hadassah Hebrew University-Medical Center, Jerusalem, Israel.
  • Stahre CA; AstraZeneca, Wilmington, DE, USA.
  • Hoekstra JB; AstraZeneca, Mölndal, Sweden.
  • Alvarsson M; Internal Medicine, University of Amsterdam, Amsterdam, Netherlands.
  • Im K; Molecular Medicine and Surgery, Endocrinology, Metabolism and Diabetes, Karolinska Institutet Solna, Stockholm, Sweden.
  • Scirica BM; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Bhatt DL; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Raz I; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Diabetes Obes Metab ; 18(2): 186-90, 2016 Feb.
Article in En | MEDLINE | ID: mdl-26443993
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Adamantane / Diabetes Mellitus, Type 2 / Dipeptides / Dipeptidyl-Peptidase IV Inhibitors / Neoplasms Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Year: 2016 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Adamantane / Diabetes Mellitus, Type 2 / Dipeptides / Dipeptidyl-Peptidase IV Inhibitors / Neoplasms Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Diabetes Obes Metab Year: 2016 Document type: Article